Skip to main content

vTv Therapeutics Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

VTVT$21.18+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

vTv THERAPEUTICS INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2026

PAGENUMBER
PART I – FINANCIAL INFORMATION
Item 1.Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 20254
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 20255
Unaudited Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2026 and 20256
Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 20258
Notes to Unaudited Consolidated Financial Statements9
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3.Quantitative and Qualitative Disclosures About Market Risk27
Item 4.Controls and Procedures27
PART II – OTHER INFORMATION
Item 1.Legal Proceedings28
Item 1A.Risk Factors28
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds28
Item 3.Defaults Upon Senior Securities28
Item 4.Mine Safety Disclosures28
Item 5.Other Information28
Item 6.Exhibits29
Signatures30
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.